Shareholders meeting

September 3, 2026 To, To, BSE Limited National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (East), Mumbai - 400051 Ref:- Scrip Code:- 500126 Ref:-NSE Symbol:- PGHL Dear Sir/Madam, Sub: Proceedings of the 59th Annual General Meeting (AGM) of Shareholders held on September 3, 2026 Pursuant to Regulation 30 read with Para A (13) of Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the 59th Annual General Meeting of the Company was held on September 3, 2026 at 2:30 p.m. through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). In this respect, please find enclosed a summary of proceedings of the 59th Annual General Meeting. Further, we have enclosed copy of presentation of the Company as presented at the 59th Annual General Meeting. Kindly take the above on record and oblige. Thanking you, Yours faithfully, For Procter & Gamble Health Limited Flavia Machado Authorized Signatory Summary of the proceedings of the 59th Annual General Meeting of Procter & Gamble Health Limited held on Thursday, September 3, 2026 at 2:30 p.m. through Video Conference / Other Audio-Visual Means The meeting commenced at 2:30 p.m. as the requisite quorum was present. Ms. Flavia Machado, Senior Manager- Secretarial, welcomed the shareholders to the 59th Annual General Meeting (AGM). Mr. S Madhavan chaired the meeting. The Chairman welcomed all the Members and called the meeting to order. The Chairman informed the Shareholders that the AGM is being conducted through video conference and other audio-visual means as permitted by the Ministry of Corporate Affairs (MCA). The Notice of AGM along with the Annual Report for the financial year 2025-26 were sent to the shareholders electronically and a letter with the web-link of the annual report and notice of the meeting was sent to shareholders whose email IDs were not updated with the Company in accordance with the MCA and SEBI circulars. The Chairman then introduced the Board members and management officials, present for the meeting as follows. Mr. Milind Thatte, Managing Director Mr. Shashank Srowthy, Chief Financial Officer and Executive Director Mr. Sharad Tyagi, Independent Director Ms. Krishna Sarma, Independent Director Mr. Aalok Agrawal, Non-Executive Director Ms. Seema Sambasivan, Non-Executive Director Ms. Flavia Machado, Senior Manager- Secretarial It was updated that the representatives of the Statutory Auditors and Secretarial Auditors had also joined this Meeting. The Chairman further informed the Auditors’ Report did not contain any qualifications or observations. Ms. Flavia Machado, Senior Manager- Secretarial, briefed the Members through the general instructions regarding virtual participation in this AGM, resolutions being put through vote and e-voting process. Live streaming of the meeting was also available on the NSDL website. She also informed the members that the requisite statutory registers were available for electronic inspection for the shareholders who wished to view the same, on the e-voting system. Ms. Machado, further updated that the Company had provided an e-voting facility for members to cast their vote through remote e-voting, which commenced on Monday, August 31, 2026 at 9:00 a.m. and ended on Wednesday, September 2, 2026 at 5:00 p.m. Those Members who had not done so were eligible to vote through the e-voting system within 30 minutes post conclusion of this AGM. Mr. Nrupang B. Dholakia was appointed as the Scrutinizer for conducting the scrutiny of votes cast through e-voting at the meeting. The resolutions proposed to be passed at the Annual General Meeting contained in the Notice convening the Meeting, which was circulated to the Members, and read by Ms. Flavia Machado, were: Sr. No. Item Ordinary Business 1 To receive, consider and adopt the Audited Balance Sheet as at March 31, 2026 and the Statement of Profit and Loss for the Financial Year ended on that date, together with the Reports of the Auditors and Directors thereon. (Ordinary Resolution) 2 To confirm payment of interim dividend and declare final dividend for the Financial Year ended March 31, 2026. (Ordinary Resolution) 3 To appoint a director in place of Mr. Aalok Agrawal, Non-Executive Director, who retires by rotation and being eligible, offers himself for re- appointment. (Ordinary Resolution) Special Business 4 To ratify remuneration payable to the Cost Auditor for the Financial Year 2026-27. (Ordinary Resolution) 5 To re-appointment of Mr. S. Madhavan as Non-Executive Independent Director of the Company for a period of five years, effective November 15, 2026. (Special Resolution) Mr. Milind Thatte, Managing Director, provided an overview on the Company’s business performance (presentation is attached as Annexure 1) The Chairman invited the Members for their comments and questions on the Financial Accounts and the Annual Report. Then the Members raised questions and made observations relating to the Annual Accounts and the Annual Report. The Management responded to the queries raised by the Members. The Chairman informed the Members that the results of the voting would be announced on receipt of the Scrutinizer’s Report, within 2 working days of the conclusion of the meeting to the Stock Exchanges and would be made available on the website of the Company. The Meeting concluded at 3:55 p.m. The Members who had not completed voting earlier and intended to do so were given 30 minutes to complete the e-voting on NSDL portal. The e-voting portal closed at 4:25 p.m. For Procter & Gamble Health Limited Flavia Machado Authorized Signatory Annual General Meeting 2025-26 3 September 2026 AGENDA • Business Results • Strategy and Fiscal Updates • Landscape, Trends & Outlook Fiscal Results 2025-26 DELIVERED A STRONG YEAR FY 2025-26 Strong, consistent Balanced Growth 16 +30% SALES PAT Considering that the company, effective last year, changed its Financial Year from July 1 –June 30 to April 1 – March 31, the last Financial Year of the Company covered a period of 9 months, from July 1, 2024, to March 31, 2025. The company performance has therefore been indexed versus the comparable 12-months period in the last year (April 1,2024, to March 31, 2025). The performance versus a 9-month past fiscal will not be comparable. INTEGRATED GROWTH STRATEGY PORTFOLIO PERFORMANCE DRIVES BRAND CHOICE SUPERIORITY ORGANIZATION TO WIN WITH CONSUMERS EMPOWERED • AGILE ACCOUNTABLE CONSTRUCTIVE DISRUPTION PRODUCTIVITY ACROSS OUR BUSINESS TO FUEL INVESTMENTS PORTFOLIO PERFORMANCE DRIVES BRAND CHOICE NEUROTROPIC VITAMINS IRON VITAMIN E PORTFOLIO VITAMIN B Trusted, Quality, Highly NASAL CARE OMEGA - 3 COMPLEX Recommended Brands SUPERIORITY TO WIN WITH CONSUMERS SUPERIORITY TO WIN WITH CONSUMERS RETAIL PRODUCT PACKAGING COMMUNICATION CONSUMER & EXECUTION CUSTOMER VALUE Superior Innovations To Delight Consumers PRODUCT Easy-To-Consume Symptomatic Relief Superior Iron Supplement from Nerve Pain Fatty Liver Solution Packaging that educates, and stands out in store PACKAGING BEFORE AFTER RETAIL EXECUTION PRODUCTIVITY TO FUEL INVESTMENTS PRODUCTIVITY INTEGRATED INTO THE STRATEGY Delivering the same or better output measures… with lower spending or resource investment. AD SPEND & MATERIALS MANUFACTURING OVERHEAD PROMOTION INR 35 crores productivity savings for FY 25/26 CONSTRUCTIVE DISRUPTION ACROSS THE BUSINESS CONSTRUCTIVE DISRUPTION ACROSS THE BUSINESS Health Care Practitioners/ LEVERAGING EXTRA URBAN Health Care EMERGING COVERAGE Organizations / CHANNELS EXPANSION Chemist + (E-pharmacies, E-com, Q-Com) DISTRIBUTOR PARTNERSHIPS Winning model enabling Available to consumers Expanding reach to white- last mile reach where they are space extra urban markets ORGANIZATION EMPOWERED • AGILE • ACC [Showing first 8,000 characters — download PDF for full document]